["{\n\"step_by_step_thinking\": \"The patient has undergone breast conservation therapy and chemotherapy for ER-positive breast cancer with one positive axillary lymph node. She is now on tamoxifen. Given the effectiveness of tamoxifen in treating advanced breast cancer, it's likely that she will continue to receive tamoxifen as part of her adjuvant therapy. The American Society of Clinical Oncology (ASCO) recommends routine clinical examination every 3-6 months and annual mammography for patients with early-stage breast cancer receiving adjuvant endocrine therapy. Therefore, option C is the most appropriate follow-up plan.\",\n\"answer_choice\": \"C\""]